{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:41:17Z","timestamp":1760150477691,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Pisa"},{"name":"NanoString Technologies Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cytological diagnosis of pleural mesothelioma (PM) is controversial, even using ancillary markers (BAP1, MTAP and CDKN2A). Here, we aimed to prospectively validate a previously developed 117-gene expression panel for the differential cytological diagnosis of epithelioid, biphasic PM and mesothelial hyperplasia. Seventy-seven pleural effusions were classified using the 117-gene expression levels (NanoString system). Sixty-eight cases were also screened for ancillary markers. The performance of both gene panel and ancillary markers was evaluated using ROC metrics. A score using the top consistently deregulated genes between epithelioid and biphasic PM was built to subtype malignant effusions. The panel alone reached a diagnostic accuracy (0.89) comparable to the best marker combination (BAP1 plus MTAP: 0.88). Ancillary tests missed 8 PMs, 7 of which were correctly classified by the panel. The score built by averaging the expression levels of MSLN, CLDN15 and CFB showed an accuracy of 0.80 in subtyping epithelioid and biphasic effusions. The 117-gene panel is effective for PM cytological diagnosis of epithelioid and biphasic PM. This tool can be complementary to ancillary markers, reducing invasive procedures and allowing an earlier diagnosis. Finally, the possibility to subtype PM on effusions strengthens the panel\u2019s role in PM diagnosis and management.<\/jats:p>","DOI":"10.3390\/cancers15235534","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T08:47:43Z","timestamp":1700642863000},"page":"5534","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of a Gene Expression Approach for the Cytological Diagnosis of Epithelioid and Biphasic Pleural Mesothelioma on a Consecutive Series"],"prefix":"10.3390","volume":"15","author":[{"given":"Rossella","family":"Bruno","sequence":"first","affiliation":[{"name":"Unit of Pathological Anatomy, University Hospital of Pisa, Via Roma 67, 56126 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-8249","authenticated-orcid":false,"given":"Anello Marcello","family":"Poma","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi 10, 56126 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta","family":"Al\u00ec","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi 10, 56126 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnese","family":"Proietti","sequence":"additional","affiliation":[{"name":"Unit of Pathological Anatomy, University Hospital of Pisa, Via Roma 67, 56126 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ribechini","sequence":"additional","affiliation":[{"name":"Endoscopic Section of Pneumology, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4325-759X","authenticated-orcid":false,"given":"Antonio","family":"Chella","sequence":"additional","affiliation":[{"name":"Unit of Pneumology, University Hospital of Pisa, Via Paradisa 2, 56124 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fontanini","sequence":"additional","affiliation":[{"name":"Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Via Savi 10, 56126 Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant Mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.annonc.2021.11.005","article-title":"Malignant Pleural Mesothelioma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"33","author":"Popat","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in Malignant Mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jtho.2021.12.014","article-title":"The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification","volume":"17","author":"Sauter","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/pin.13235","article-title":"Update of Pathological Diagnosis of Pleural Mesothelioma Using Genomic-based Morphological Techniques, for Both Histological and Cytological Investigations","volume":"72","author":"Nabeshima","year":"2022","journal-title":"Pathol. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5644\/ama2006-124.335","article-title":"Update on Diagnosing and Reporting Malignant Pleural Mesothelioma","volume":"50","author":"Savic","year":"2021","journal-title":"Acta Med. Acad."},{"key":"ref_7","first-page":"S238","article-title":"Management of Malignant Pleural Mesothelioma-The European Experience","volume":"6","author":"Opitz","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.21037\/tlcr.2020.03.38","article-title":"Clinical Significance of Histologic Subtyping of Malignant Pleural Mesothelioma","volume":"9","author":"Brcic","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00428-021-03031-7","article-title":"Pleural Mesothelioma Classification Update","volume":"478","author":"Beasley","year":"2021","journal-title":"Virchows Arch."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41379-021-00895-7","article-title":"Pleural Mesothelioma Classification\u2014Update and Challenges","volume":"35","author":"Dacic","year":"2022","journal-title":"Mod. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","article-title":"Guidelines for Cytopathologic Diagnosis of Epithelioid and Mixed Type Malignant Mesothelioma. Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology","volume":"12","author":"Hjerpe","year":"2015","journal-title":"CytoJournal"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2018.07.041","article-title":"Highlights of the 14th International Mesothelioma Interest Group Meeting: Pathologic Separation of Benign from Malignant Mesothelial Proliferations and Histologic\/Molecular Analysis of Malignant Mesothelioma Subtypes","volume":"124","author":"Churg","year":"2018","journal-title":"Lung Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2021.10.019","article-title":"The Highlights of the 15th International Conference of the International Mesothelioma Interest Group\u2014Do Molecular Concepts Challenge the Traditional Approach to Pathological Mesothelioma Diagnosis?","volume":"163","author":"Klebe","year":"2022","journal-title":"Lung Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cyt.13055","article-title":"State-of-the-Art Cytology of Pleural Fluid, Focusing on the Diagnosis of Mesothelioma","volume":"33","author":"Monaco","year":"2022","journal-title":"Cytopathol. Off. J. Br. Soc. Clin. Cytol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cncy.22326","article-title":"Testing for BAP1 Loss and CDKN2A\/P16 Homozygous Deletion Improves the Accurate Diagnosis of Mesothelial Proliferations in Effusion Cytology","volume":"128","author":"Chevrier","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 Immunohistochemistry and P16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/dc.23491","article-title":"BAP1 Immunostain and CDKN2A (P16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions","volume":"44","author":"Walts","year":"2016","journal-title":"Diagn. Cytopathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of Methylthioadenosine Phosphorylase Compared with BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations from Epithelioid Malignant Mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/his.13872","article-title":"Cytoplasmic MTAP Expression Loss Detected by Immunohistochemistry Correlates with 9p21 Homozygous Deletion Detected by FISH in Pleural Effusion Cytology of Mesothelioma","volume":"75","author":"Hamasaki","year":"2019","journal-title":"Histopathology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jasc.2022.07.003","article-title":"Diagnostic Capacity of BAP1 and MTAP in Cytology from Effusions and Biopsy in Mesothelioma","volume":"11","author":"Panou","year":"2022","journal-title":"J. Am. Soc. Cytopathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.18632\/oncotarget.13174","article-title":"Malignant Pleural Mesothelioma and Mesothelial Hyperplasia: A New Molecular Tool for the Differential Diagnosis","volume":"8","author":"Bruno","year":"2017","journal-title":"Oncotarget"},{"key":"ref_22","first-page":"1060","article-title":"A Gene-expression-based Test Can Outperform Bap1 and P16 Analyses in the Differential Diagnosis of Pleural Mesothelial Proliferations","volume":"19","author":"Bruno","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jmoldx.2019.12.009","article-title":"Differential Diagnosis of Malignant Pleural Mesothelioma on Cytology","volume":"22","author":"Bruno","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bruno, R., Poma, A.M., Al\u00ec, G., Distefano, C., Proietti, A., Chella, A., Lucchi, M., Melfi, F., Franco, R., and Fontanini, G. (2022). Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030674"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/modpathol.2015.87","article-title":"Loss of Expression of BAP1 Is a Useful Adjunct, Which Strongly Supports the Diagnosis of Mesothelioma in Effusion Cytology","volume":"28","author":"Andrici","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/dc.23837","article-title":"Loss of BRCA1-Associated Protein 1 (BAP1) Expression Is Useful in Diagnostic Cytopathology of Malignant Mesothelioma in Effusions","volume":"46","author":"Cozzi","year":"2018","journal-title":"Diagn. Cytopathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical Detection of MTAP and BAP1 Protein Loss for Mesothelioma Diagnosis: Comparison with 9p21 FISH and BAP1 Immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct Multiplexed Measurement of Gene Expression with Color-Coded Probe Pairs","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14737159.2017.1268533","article-title":"NanoString, a Novel Digital Color-Coded Barcode Technology: Current and Future Applications in Molecular Diagnostics","volume":"17","author":"Tsang","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"42259","DOI":"10.1038\/srep42259","article-title":"Multiplexed Transcriptome Analysis to Detect ALK, ROS1 and RET Rearrangements in Lung Cancer","volume":"7","author":"Rogers","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jtho.2018.04.023","article-title":"New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center","volume":"13","author":"Nicholson","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00428-014-1664-9","article-title":"Reproducibility of Histological Subtyping of Malignant Pleural Mesothelioma","volume":"465","author":"Seiwerth","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ebiom.2019.09.003","article-title":"Redefining Malignant Pleural Mesothelioma Types as a Continuum Uncovers Immune-Vascular Interactions","volume":"48","author":"Alcala","year":"2019","journal-title":"eBioMedicine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive Genomic Analysis of Malignant Pleural Mesothelioma Identifies Recurrent Mutations, Gene Fusions and Splicing Alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/23\/5534\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:27:25Z","timestamp":1760131645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/23\/5534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":34,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["cancers15235534"],"URL":"https:\/\/doi.org\/10.3390\/cancers15235534","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}